ResearchHub | Open Science Community

Annie Clark

Author with expertise in Viral RNA Silencing and Plant Immunity

Achievements

This user has not unlocked any achievements yet.

Key Stats

Upvotes received:

Publications:

(20% Open Access)

Cited by:

h-index:

i10-index:

Reputation

Biology

< 1%

Chemistry

< 1%

Economics

< 1%

How is this calculated?

Publications

Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Study

Ian Glaspole et al.Jun 6, 2024

Idiopathic pulmonary fibrosis (IPF) is a rare and progressive disease that causes progressive cough, exertional dyspnea, impaired quality of life, and death.

Internal Medicine

Plant Science

Paper

Internal Medicine

Save

CSF Proteomics in Patients With Progressive Supranuclear Palsy

Amy Wise et al.Jul 3, 2024

Identification of fluid biomarkers for progressive supranuclear palsy (PSP) is critical to enhance therapeutic development. We implemented unbiased DNA aptamer (SOMAmer) proteomics to identify novel CSF PSP biomarkers.

Genetics

Physiology

Paper

Genetics

Save

LBP-039 Oral alpha-v/beta-6 and alpha-v/beta-1 integrin inhibitor bexotegrast in primary sclerosing cholangitis: updated 12-week interim safety and efficacy analysis of the INTEGRIS-PSC phase 2a trial

Michael Trauner et al.Jun 1, 2024

Paper

Save

Safety and tolerability of bexotegrast in Phase 2 trials of idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC)

Gregory Cosgrove et al.Sep 14, 2024

Paper

Save

Late Breaking Abstract - Bexotegrast reduces type 1 collagen deposition in participants with idiopathic pulmonary fibrosis (IPF) after 12 weeks of therapy

Sydney Montesi et al.Sep 14, 2024

Internal Medicine

Pulmonary And Respiratory Medicine

Paper

Internal Medicine

Pulmonary And Respiratory Medicine

Save